0 XP   0   0   0

Oxurion NV
Buy, Hold or Sell?

Should you buy, hold or sell Oxurion?

I guess you are interested in Oxurion NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Oxurion

Let's start. I'm going to help you getting a better view of Oxurion NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Oxurion NV even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Oxurion NV is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Oxurion NV. The closing price on 2023-02-07 was €0.014 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Oxurion NV Daily Candlestick Chart
Oxurion NV Daily Candlestick Chart
Summary









1. Valuation of Oxurion




Current price per share

€0.01

2. Growth of Oxurion




Is Oxurion growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.1m$26.8m-$28m-2,360.6%

How much money is Oxurion making?

Current yearPrevious yearGrowGrow %
Making money-$31.2m-$30m-$1.2m-3.9%
Net Profit Margin-2,584.9%-1,348.0%--

How much money comes from the company's main activities?

3. Financial Health of Oxurion




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#1103 / 1232

Most Revenue
#515 / 1232

Most Profit
#987 / 1232

Most Efficient
#1038 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

1.1. Profitability of Oxurion NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oxurion earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Net Profit Margin of -2,584.9% means that €-25.85 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oxurion NV:

  • The MRQ is -2,584.9%. The company is making a huge loss. -2
  • The TTM is -2,584.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,584.9%TTM-2,584.9%0.0%
TTM-2,584.9%YOY-1,348.0%-1,236.9%
TTM-2,584.9%5Y-1,143.6%-1,441.3%
5Y-1,143.6%10Y-721.2%-422.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,584.9%-223.6%-2,361.3%
TTM-2,584.9%-281.7%-2,303.2%
YOY-1,348.0%-344.8%-1,003.2%
5Y-1,143.6%-450.1%-693.5%
10Y-721.2%-541.0%-180.2%
1.1.2. Return on Assets

Shows how efficient Oxurion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • -154.5% Return on Assets means that Oxurion generated €-1.54 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oxurion NV:

  • The MRQ is -154.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -154.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-154.5%TTM-154.5%0.0%
TTM-154.5%YOY-81.7%-72.8%
TTM-154.5%5Y-66.8%-87.6%
5Y-66.8%10Y-40.6%-26.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-154.5%-9.9%-144.6%
TTM-154.5%-8.9%-145.6%
YOY-81.7%-9.3%-72.4%
5Y-66.8%-11.7%-55.1%
10Y-40.6%-12.7%-27.9%
1.1.3. Return on Equity

Shows how efficient Oxurion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • 0.0% Return on Equity means Oxurion generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oxurion NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-111.2%+111.2%
TTM-5Y-45.6%+45.6%
5Y-45.6%10Y-30.6%-15.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--11.5%+11.5%
YOY-111.2%-10.8%-100.4%
5Y-45.6%-14.2%-31.4%
10Y-30.6%-15.2%-15.4%

1.2. Operating Efficiency of Oxurion NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oxurion is operating .

  • Measures how much profit Oxurion makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • An Operating Margin of -2,582.4% means the company generated €-25.82  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oxurion NV:

  • The MRQ is -2,582.4%. The company is operating very inefficient. -2
  • The TTM is -2,582.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,582.4%TTM-2,582.4%0.0%
TTM-2,582.4%YOY-1,346.8%-1,235.6%
TTM-2,582.4%5Y-1,142.4%-1,440.0%
5Y-1,142.4%10Y-720.4%-422.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,582.4%-207.3%-2,375.1%
TTM-2,582.4%-271.0%-2,311.4%
YOY-1,346.8%-325.9%-1,020.9%
5Y-1,142.4%-454.0%-688.4%
10Y-720.4%-537.1%-183.3%
1.2.2. Operating Ratio

Measures how efficient Oxurion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 25.26 means that the operating costs are €25.26 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Oxurion NV:

  • The MRQ is 25.262. The company is inefficient in keeping operating costs low. -1
  • The TTM is 25.262. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ25.262TTM25.2620.000
TTM25.262YOY14.713+10.550
TTM25.2625Y11.345+13.918
5Y11.34510Y7.323+4.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ25.2622.871+22.391
TTM25.2623.504+21.758
YOY14.7133.604+11.109
5Y11.3455.132+6.213
10Y7.3236.371+0.952

1.3. Liquidity of Oxurion NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oxurion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.23 means the company has €1.23 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Oxurion NV:

  • The MRQ is 1.229. The company is just able to pay all its short-term debts.
  • The TTM is 1.229. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.229TTM1.2290.000
TTM1.229YOY3.517-2.288
TTM1.2295Y5.409-4.180
5Y5.40910Y8.935-3.526
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2295.117-3.888
TTM1.2295.755-4.526
YOY3.5175.854-2.337
5Y5.4096.511-1.102
10Y8.9356.222+2.713
1.3.2. Quick Ratio

Measures if Oxurion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Quick Ratio of 1.23 means the company can pay off €1.23 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oxurion NV:

  • The MRQ is 1.231. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.231. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.231TTM1.2310.000
TTM1.231YOY3.511-2.280
TTM1.2315Y6.416-5.186
5Y6.41610Y9.250-2.834
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2314.284-3.053
TTM1.2314.664-3.433
YOY3.5114.787-1.276
5Y6.4165.218+1.198
10Y9.2505.182+4.068

1.4. Solvency of Oxurion NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oxurion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oxurion to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.06 means that Oxurion assets are financed with 105.9% credit (debt) and the remaining percentage (100% - 105.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oxurion NV:

  • The MRQ is 1.059. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.059. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.059TTM1.0590.000
TTM1.059YOY0.269+0.789
TTM1.0595Y0.341+0.718
5Y0.34110Y0.200+0.141
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0590.278+0.781
TTM1.0590.277+0.782
YOY0.2690.306-0.037
5Y0.3410.367-0.026
10Y0.2000.403-0.203
1.4.2. Debt to Equity Ratio

Measures if Oxurion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oxurion to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oxurion NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.367-0.367
TTM-5Y0.161-0.161
5Y0.16110Y0.113+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.315-0.315
TTM-0.317-0.317
YOY0.3670.319+0.048
5Y0.1610.403-0.242
10Y0.1130.462-0.349

2. Market Valuation of Oxurion NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Oxurion generates.

  • Above 15 is considered overpriced but always compare Oxurion to the Biotechnology industry mean.
  • A PE ratio of -25.60 means the investor is paying €-25.60 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oxurion NV:

  • The EOD is -0.197. Company is losing money. -2
  • The MRQ is -25.602. Company is losing money. -2
  • The TTM is -25.602. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.197MRQ-25.602+25.405
MRQ-25.602TTM-25.6020.000
TTM-25.602YOY-37.494+11.892
TTM-25.6025Y-12.829-12.773
5Y-12.82910Y70.958-83.787
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.197-8.986+8.789
MRQ-25.602-9.792-15.810
TTM-25.602-16.243-9.359
YOY-37.494-20.876-16.618
5Y-12.829-16.665+3.836
10Y70.958-14.732+85.690
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Oxurion.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Oxurion NV:

  • The MRQ is -26.694. Very Bad. -2
  • The TTM is -26.694. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-26.694TTM-26.6940.000
TTM-26.694YOY-25.690-1.005
TTM-26.6945Y-7.929-18.765
5Y-7.92910Y44.320-52.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.694-0.032-26.662
TTM-26.6940.004-26.698
YOY-25.6900.016-25.706
5Y-7.9290.006-7.935
10Y44.3200.003+44.317

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oxurion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -673.74 means the investor is paying €-673.74 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Oxurion NV:

  • The EOD is -5.194. Bad. Book ratio is negative. -2
  • The MRQ is -673.743. Bad. Book ratio is negative. -2
  • The TTM is -673.743. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-5.194MRQ-673.743+668.549
MRQ-673.743TTM-673.7430.000
TTM-673.743YOY41.931-715.674
TTM-673.7435Y-116.901-556.842
5Y-116.90110Y-44.570-72.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.1941.835-7.029
MRQ-673.7432.006-675.749
TTM-673.7432.774-676.517
YOY41.9313.453+38.478
5Y-116.9012.713-119.614
10Y-44.5702.402-46.972
2. Total Gains per Share

2.4. Latest News of Oxurion NV

Does Oxurion NV still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Oxurion NV to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-02-03
19:00
Oxurion Receives Transparency Notifications from Negma GroupRead
2023-01-27
08:01
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMARead
2023-01-25
08:59
Oxurion Announces Second Amendment to Negma Funding ProgramRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oxurion NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.064-0.0640%-0.069+8%-0.054-15%-0.029-54%
Book Value Growth---0.044-0.0440%0.470-109%0.587-108%0.827-105%
Book Value Per Share---0.003-0.0030%0.061-104%0.154-102%0.314-101%
Book Value Per Share Growth---0.044-0.0440%0.470-109%0.587-108%0.827-105%
Current Ratio--1.2291.2290%3.517-65%5.409-77%8.935-86%
Debt To Asset Ratio--1.0591.0590%0.269+293%0.341+210%0.200+429%
Debt To Equity Ratio----0%0.367-100%0.161-100%0.113-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.071-0.0710%-0.068-4%-0.061-14%-0.053-26%
Eps Growth--0.9590.9590%1.460-34%0.752+28%0.777+24%
Free Cash Flow Per Share---0.066-0.0660%-0.066+1%-0.044-33%-0.043-34%
Free Cash Flow Per Share Growth--1.0071.0070%1.128-11%1.025-2%1.127-11%
Free Cash Flow To Equity Per Share---0.037-0.0370%-0.068+85%-0.034-7%-0.019-49%
Free Cash Flow To Equity Per Share Growth--1.4581.4580%1.123+30%1.267+15%1.143+28%
Gross Profit Margin--0.9990.9990%1.023-2%1.007-1%0.959+4%
Intrinsic Value_10Y_max--14.181--------
Intrinsic Value_10Y_min---0.519--------
Intrinsic Value_1Y_max--0.255--------
Intrinsic Value_1Y_min---0.066--------
Intrinsic Value_3Y_max--1.656--------
Intrinsic Value_3Y_min---0.186--------
Intrinsic Value_5Y_max--4.127--------
Intrinsic Value_5Y_min---0.295--------
Net Profit Margin---25.849-25.8490%-13.480-48%-11.436-56%-7.212-72%
Operating Margin---25.824-25.8240%-13.468-48%-11.424-56%-7.204-72%
Operating Ratio--25.26225.2620%14.713+72%11.345+123%7.323+245%
Pb Ratio-5.194+99%-673.743-673.7430%41.931-1707%-116.901-83%-44.570-93%
Pe Ratio-0.197+99%-25.602-25.6020%-37.494+46%-12.829-50%70.958-136%
Peg Ratio---26.694-26.6940%-25.690-4%-7.929-70%44.320-160%
Price Per Share0.014-12871%1.8161.8160%2.555-29%2.865-37%8.915-80%
Price To Total Gains Ratio-0.220+99%-28.541-28.5410%-37.168+30%-16.580-42%23.457-222%
Profit Growth--0.9590.9590%1.460-34%0.752+28%0.777+24%
Quick Ratio--1.2311.2310%3.511-65%6.416-81%9.250-87%
Return On Assets---1.545-1.5450%-0.817-47%-0.668-57%-0.406-74%
Return On Equity----0%-1.1120%-0.4560%-0.3060%
Revenue Growth--0.5430.5430%0.527+3%0.735-26%3.707-85%
Total Gains Per Share---0.064-0.0640%-0.069+8%-0.054-15%-0.029-54%
Total Gains Per Share Growth--1.0741.0740%1.457-26%0.775+39%1.163-8%
Usd Book Value---1188884.000-1188884.0000%26876504.000-104%67794929.800-102%138474620.100-101%
Usd Book Value Change Per Share---0.068-0.0680%-0.074+8%-0.058-15%-0.031-54%
Usd Book Value Per Share---0.003-0.0030%0.065-104%0.165-102%0.337-101%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.076-0.0760%-0.073-4%-0.065-14%-0.057-26%
Usd Free Cash Flow---28981730.000-28981730.0000%-29183454.000+1%-19458425.800-33%-18999932.900-34%
Usd Free Cash Flow Per Share---0.071-0.0710%-0.071+1%-0.047-33%-0.046-34%
Usd Free Cash Flow To Equity Per Share---0.040-0.0400%-0.073+85%-0.037-7%-0.020-49%
Usd Price Per Share0.015-12871%1.9491.9490%2.742-29%3.074-37%9.565-80%
Usd Profit---31286534.000-31286534.0000%-30056876.000-4%-26756971.800-14%-23303414.000-26%
Usd Revenue--1210344.0001210344.0000%2229694.000-46%4619694.200-74%25909623.700-95%
Usd Total Gains Per Share---0.068-0.0680%-0.074+8%-0.058-15%-0.031-54%
 EOD+2 -3MRQTTM+0 -0YOY+16 -235Y+9 -3010Y+9 -30

3.2. Fundamental Score

Let's check the fundamental score of Oxurion NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.197
Price to Book Ratio (EOD)Between0-1-5.194
Net Profit Margin (MRQ)Greater than0-25.849
Operating Margin (MRQ)Greater than0-25.824
Quick Ratio (MRQ)Greater than11.231
Current Ratio (MRQ)Greater than11.229
Debt to Asset Ratio (MRQ)Less than11.059
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.545
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Oxurion NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.016
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Total Stockholder Equity 132,630-27,742104,888-51,72853,160-27,98025,180-26,258-1,078
Net Debt  -56,175-8,477-64,65224,393-40,25916,844-23,41525,7742,359
Net Tangible Assets  109,027-24,58984,438-33,26051,178-28,12523,053-25,131-2,078
Selling and Marketing Expenses  1,5302891,819-421,777-1,131646-674-28



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets18,876
Total Liabilities19,984
Total Stockholder Equity-1,078
 As reported
Total Liabilities 19,984
Total Stockholder Equity+ -1,078
Total Assets = 18,876

Assets

Total Assets18,876
Total Current Assets13,409
Long-term Assets13,409
Total Current Assets
Cash And Cash Equivalents 9,740
Short-term Investments 247
Net Receivables 3,198
Inventory 60
Total Current Assets  (as reported)13,409
Total Current Assets  (calculated)13,245
+/- 164
Long-term Assets
Property Plant Equipment 372
Intangible Assets 1,000
Other Assets 4,095
Long-term Assets  (as reported)5,467
Long-term Assets  (calculated)5,467
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,913
Long-term Liabilities9,071
Total Stockholder Equity-1,078
Total Current Liabilities
Short-term Debt 3,622
Short Long Term Debt 3,401
Accounts payable 4,979
Other Current Liabilities 2,312
Total Current Liabilities  (as reported)10,913
Total Current Liabilities  (calculated)14,314
+/- 3,401
Long-term Liabilities
Long term Debt 8,433
Capital Lease Obligations 265
Other Liabilities 594
Long-term Liabilities  (as reported)9,071
Long-term Liabilities  (calculated)9,292
+/- 221
Total Stockholder Equity
Common Stock46,029
Retained Earnings -41,719
Other Stockholders Equity -5,388
Total Stockholder Equity (as reported)-1,078
Total Stockholder Equity (calculated)-1,078
+/-0
Other
Capital Stock46,029
Cash and Short Term Investments 9,987
Common Stock Shares Outstanding 31,427
Liabilities and Stockholders Equity 18,906
Net Debt 2,359
Net Invested Capital 10,756
Net Tangible Assets -2,078
Net Working Capital 2,496
Short Long Term Debt Total 12,099



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
> Total Assets 
37,334
51,997
67,203
101,219
142,937
129,089
239,171
271,154
220,714
178,946
121,636
150,437
114,864
65,030
34,284
18,876
18,87634,28465,030114,864150,437121,636178,946220,714271,154239,171129,089142,937101,21967,20351,99737,334
   > Total Current Assets 
34,218
48,354
61,448
80,108
113,477
87,784
159,751
191,634
149,168
116,693
91,439
124,283
91,089
57,015
27,054
13,409
13,40927,05457,01591,089124,28391,439116,693149,168191,634159,75187,784113,47780,10861,44848,35434,218
       Cash And Cash Equivalents 
32,043
40,111
30,356
75,929
85,866
57,548
139,398
164,570
123,223
93,341
58,251
56,175
64,652
42,492
24,511
9,740
9,74024,51142,49264,65256,17558,25193,341123,223164,570139,39857,54885,86675,92930,35640,11132,043
       Short-term Investments 
718
6,710
28,565
742
23,289
22,831
8,833
7,791
3,853
8,044
21,817
49,555
20,475
10,444
288
247
24728810,44420,47549,55521,8178,0443,8537,7918,83322,83123,28974228,5656,710718
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
7,535
5,867
4,005
3,453
1,924
3,198
3,1981,9243,4534,0055,8677,5350000000000
       Other Current Assets 
1,457
1,533
2,527
3,437
4,322
7,405
11,520
16,068
18,509
11,341
8,867
16,349
4,926
4,059
2,170
3,362
3,3622,1704,0594,92616,3498,86711,34118,50916,06811,5207,4054,3223,4372,5271,5331,457
   > Long-term Assets 
3,116
3,643
5,755
21,111
29,460
41,305
79,420
79,520
71,546
62,253
30,197
26,154
23,775
8,015
7,230
5,467
5,4677,2308,01523,77526,15430,19762,25371,54679,52079,42041,30529,46021,1115,7553,6433,116
       Property Plant Equipment 
530
1,057
1,004
1,042
894
1,492
2,699
3,634
2,911
2,088
1,743
991
614
2,552
1,299
372
3721,2992,5526149911,7432,0882,9113,6342,6991,4928941,0421,0041,057530
       Goodwill 
2,586
2,586
2,586
2,586
2,586
0
2,586
2,586
2,586
2,586
0
0
0
0
0
0
0000002,5862,5862,5862,58602,5862,5862,5862,5862,586
       Intangible Assets 
0
0
2,092
17,357
25,832
0
72,338
69,209
62,388
55,699
25,902
23,603
20,450
1,982
2,127
1,000
1,0002,1271,98220,45023,60325,90255,69962,38869,20972,338025,83217,3572,09200
       Other Assets 
0
0
0
0
0
0
0
0
0
0
2,552
1,560
2,711
3,481
3,804
4,095
4,0953,8043,4812,7111,5602,5520000000000
> Total Liabilities 
2,056
3,562
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
11,724
9,236
19,984
19,9849,23611,7249,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,5622,056
   > Total Current Liabilities 
2,027
3,601
4,810
7,501
4,747
11,060
11,205
12,382
12,702
8,931
11,777
17,080
9,554
10,389
7,693
10,913
10,9137,69310,3899,55417,08011,7778,93112,70212,38211,20511,0604,7477,5014,8103,6012,027
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
898
649
3,622
3,6226498980000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,401
3,401000000000000000
       Accounts payable 
1,785
0
0
6,688
4,034
9,336
9,303
10,352
7,369
4,128
5,941
3,298
5,054
4,725
4,377
4,979
4,9794,3774,7255,0543,2985,9414,1287,36910,3529,3039,3364,0346,688001,785
       Other Current Liabilities 
242
3,601
4,810
813
713
1,724
1,902
2,030
5,333
4,803
5,836
13,782
4,500
4,766
2,667
2,312
2,3122,6674,7664,50013,7825,8364,8035,3332,0301,9021,7247138134,8103,601242
   > Long-term Liabilities 
29
-39
0
0
0
0
0
0
0
0
0
0
0
1,335
1,543
9,071
9,0711,5431,33500000000000-3929
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,335
0
0
001,3350000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
801
1,096
594
5941,0968010000000000000
> Total Stockholder Equity
35,278
48,435
62,393
93,718
138,190
118,029
227,966
258,772
208,012
169,938
109,816
132,630
104,888
53,160
25,180
-1,078
-1,07825,18053,160104,888132,630109,816169,938208,012258,772227,966118,029138,19093,71862,39348,43535,278
   Common Stock
95,974
110,309
111,338
125,122
138,095
138,351
150,938
151,991
151,991
151,991
151,991
151,991
137,564
100,644
44,913
46,029
46,02944,913100,644137,564151,991151,991151,991151,991151,991150,938138,351138,095125,122111,338110,30995,974
   Retained Earnings -41,719-12,561-34,747-19,853-163,546-186,334-126,068-88,136-36,792-63,193-93,608-71,971-58,029-43,959-56,054-40,087
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
-20,609
-5,820
-4,986
29,281
75,041
76,631
144,149
148,721
150,599
151,607
152,658
153,733
-2,703
-2,212
3,582
-5,388
-5,3883,582-2,212-2,703153,733152,658151,607150,599148,721144,14976,63175,04129,281-4,986-5,820-20,609



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,128
Cost of Revenue-612
Gross Profit516516
 
Operating Income (+$)
Gross Profit516
Operating Expense-27,884
Operating Income-28,495-27,368
 
Operating Expense (+$)
Research Development20,696
Selling General Administrative4,731
Selling And Marketing Expenses-28
Operating Expense27,88425,399
 
Net Interest Income (+$)
Interest Income9
Interest Expense-26
Net Interest Income-730-17
 
Pretax Income (+$)
Operating Income-28,495
Net Interest Income-730
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-29,592-27,398
EBIT - interestExpense = -29,155
-29,155
-29,132
Interest Expense26
Earnings Before Interest and Taxes (ebit)-29,129-29,566
Earnings Before Interest and Taxes (ebitda)-27,325
 
After tax Income (+$)
Income Before Tax-29,592
Tax Provision-3
Net Income From Continuing Ops-29,595-29,595
Net Income-29,158
Net Income Applicable To Common Shares-29,158
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses28,496
Total Other Income/Expenses Net-1,097730
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PRINCEPIPE.BSE
1 minute ago

I found you a Golden Cross on the daily chart of PRINCEPIPE.BSE.

PRINCEPIPE.BSE Daily Candlestick Chart
PODDAR.BSE
2 minutes ago

I found you a Death Cross on the daily chart of PODDAR.BSE.

PODDAR.BSE Daily Candlestick Chart
PALCO.BSE
6 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PALCO.BSE.

PALCO.BSE Daily Candlestick Chart
NYSSACORP.BSE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NYSSACORP.BSE.

NYSSACORP.BSE Daily Candlestick Chart
MSL.BSE
13 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of MSL.BSE.

MSL.BSE Daily Candlestick Chart
MONTECARLO.BSE
14 minutes ago

I found you a Death Cross on the daily chart of MONTECARLO.BSE.

MONTECARLO.BSE Daily Candlestick Chart
MEDICAMEQ.BSE
16 minutes ago

I found you a Death Cross on the daily chart of MEDICAMEQ.BSE.

MEDICAMEQ.BSE Daily Candlestick Chart
MADRASFERT.BSE
19 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MADRASFERT.BSE.

MADRASFERT.BSE Daily Candlestick Chart
JINDWORLD.BSE
28 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of JINDWORLD.BSE.

JINDWORLD.BSE Daily Candlestick Chart
JINDALSAW.BSE
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JINDALSAW.BSE.

JINDALSAW.BSE Daily Candlestick Chart
HDIL.BSE
32 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HDIL.BSE.

HDIL.BSE Daily Candlestick Chart
GOYALALUM.NSE
33 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of GOYALALUM.NSE.

GOYALALUM.NSE Daily Candlestick Chart
GLCL.BSE
33 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of GLCL.BSE.

GLCL.BSE Daily Candlestick Chart
VINNY.BSE
34 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VINNY.BSE.

VINNY.BSE Daily Candlestick Chart
PHYTO.BSE
35 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PHYTO.BSE.

PHYTO.BSE Daily Candlestick Chart
OSIAHYPER.NSE
36 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OSIAHYPER.NSE.

OSIAHYPER.NSE Daily Candlestick Chart
VINNY.NSE
36 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VINNY.NSE.

VINNY.NSE Daily Candlestick Chart
ETT.BSE
36 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ETT.BSE.

ETT.BSE Daily Candlestick Chart
DCXINDIA.BSE
37 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of DCXINDIA.BSE.

DCXINDIA.BSE Daily Candlestick Chart
ALFATRAN.BSE
40 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALFATRAN.BSE.

ALFATRAN.BSE Daily Candlestick Chart
AFFORDABLE.BSE
42 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of AFFORDABLE.BSE.

AFFORDABLE.BSE Daily Candlestick Chart
ACEINTEG.NSE
42 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ACEINTEG.NSE.

ACEINTEG.NSE Daily Candlestick Chart
7NR.BSE
42 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 7NR.BSE.

7NR.BSE Daily Candlestick Chart